Schmicker R, Fröhling P T, Hohmann W D, Kokot F, Lindenau K, Vetter K
Z Urol Nephrol. 1984 Nov;77(11):661-70.
Starting from the results of former investigations the influence of the long-term treatment with the KA of the essential amino acids on the renal osteopathy is investigated. For this purpose we compared 27 patients with renal insufficiency (serum creatinine 981 +/- 354 mumol/l), who besides vitamin D had been treated with KA for at least 12 months, to a group of 50 patients (serum creatinine 778 +/- 273 mumol/l), who had received vitamin D over 19 +/- 9 months, and to a control group of 27 patients (serum creatinine 928 +/- mumol/l) without an adequate conservative therapy. While the control group showed the typical constellation in advanced renal insufficiency with hypocalcaemia, hyperphosphataemia, clearly increased PTH levels, clearly increased CT values and normal 25-OH-D concentrations, during the diettherapy and the vitamin D substitution a significant increase of the serum levels of calcium, 25-OH-D and CT as well as a significant decrease of the PTH and the anorganic phosphate in the serum developed. Under the combination therapy with KA and vitamin D despite the reduction of the phosphate binders another significant decrease of the PTH and the anorganic phosphate was observed. The mineral content of the bones was within the normal in the two therapy groups. The percentage of the normal histological findings of the bones was with 40.7% highest despite the advanced renal insufficiency in the simultaneous substitution with KA. While in the vitamin D group during the control biopsy after 12 months in 20.5% of the cases an improvement of the histological findings developed, this effect occurred under additional KA-therapy in 51.9% of the cases. The results allow the conclusion that by means of the long-term treatment with KA a favourable influence on the renal osteopathy develops.
从先前的研究结果出发,研究必需氨基酸酮类似物(KA)长期治疗对肾性骨病的影响。为此,我们将27例肾功能不全患者(血清肌酐981±354μmol/L)与一组50例患者(血清肌酐778±273μmol/L)以及27例未接受充分保守治疗的对照组患者(血清肌酐928±μmol/L)进行了比较。27例肾功能不全患者除维生素D外还接受KA治疗至少12个月,50例患者接受维生素D治疗19±9个月。对照组在晚期肾功能不全时表现出典型的低钙血症、高磷血症、甲状旁腺激素(PTH)水平明显升高、降钙素(CT)值明显升高以及25-羟维生素D浓度正常的情况。在饮食治疗和维生素D替代治疗期间,血清钙、25-羟维生素D和CT水平显著升高,血清中PTH和无机磷显著降低。在KA和维生素D联合治疗下,尽管磷酸盐结合剂减少,但仍观察到PTH和无机磷的进一步显著降低。两个治疗组的骨矿物质含量均在正常范围内。在同时使用KA替代治疗时,尽管肾功能不全已处于晚期,但骨组织学正常表现的百分比最高,为40.7%。维生素D组在12个月后的对照活检中有20.5%的病例组织学表现有所改善,而在额外的KA治疗下,这一比例在51.9%的病例中出现。结果表明,通过KA长期治疗对肾性骨病有有利影响。